Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Sep 12, 2024)

Date Submitted: Dec 9, 2023
Open Peer Review Period: Dec 5, 2023 - Feb 5, 2024
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Development and Validation of a Universal Multi-Module Health Education Web Platform for University Students: A Randomized Controlled Trial of HIV/AIDS Prevention

  • Guangnan Liu; 
  • Runyuan Pei; 
  • Haoming Ma; 
  • Bin Chen; 
  • Chenming Liu; 
  • Yiru Shen; 
  • Chengjie Yu; 
  • Yu Sheng

ABSTRACT

Background:

Information platforms have become a major avenue for public knowledge acquisition. However, the current framework of web platforms is not fully developed, and the needs of university students are not well understood by developers. Moreover, despite the low prevalence of HIV/AIDS in China, the situation remains critical for university student groups.

Objective:

The aim is to develop and establish a comprehensive, multi-module health education web platform tailored for university students. Specifically, to use HIV/AIDS prevention among university students as a case study to validate the effectiveness of the platform's educational modules.

Methods:

The web platform was developed following the behavioural guidelines of American medical and health websites. The modules were designed around “the three parts of a medical health education module course,” encompassing video learning, gaming, virtual community, and a question bank. Following development, experts were invited to test and refine the platform's modules. A preliminary experiment was conducted at the School of Nursing, Peking Union Medical College with nine participants, three from each grade. The platform was further refined based on these results. The study involved 146 non-medical undergraduate students from three different types of universities in Beijing, randomly divided into control (n=63) and intervention (n=63) groups. A web-based survey on Knowledge, Belief, and Practices (KBP) concerning AIDS, covering knowledge, belief, and high-risk behaviours with 36 items, was used. Baseline measurements for both groups were initially taken. The intervention group then used the web platform for three consecutive weeks, with a minimum usage of 120 minutes per week, sequentially accessing the video, gaming, and virtual community modules. The control group engaged in self-learning. Post-intervention, the total scores for knowledge, belief, and behaviour were measured for both groups.

Results:

The intervention group's baseline mean score was 22.34±1.668, and the control group's was 22.77±1.736, with no significant statistical difference in baseline data (P>0.05). After three weeks, the intervention group's average total score was 38.19±4.865, compared to 29.84±5.742 for the control group, indicating a statistically significant difference in AIDS KBP levels between the groups (P<0.05).

Conclusions:

The web platform significantly positively impacted the AIDS KBP level among university students, suggesting that it has a significant positive effect on the health education of this demographic. It is recommended to continue developing modules for diseases beyond HIV/AIDS in the future. Clinical Trial: Approval:No.2022zglc06017


 Citation

Please cite as:

Liu G, Pei R, Ma H, Chen B, Liu C, Shen Y, Yu C, Sheng Y

Development and Validation of a Universal Multi-Module Health Education Web Platform for University Students: A Randomized Controlled Trial of HIV/AIDS Prevention

JMIR Preprints. 09/12/2023:54947

DOI: 10.2196/preprints.54947

URL: https://preprints.jmir.org/preprint/54947

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.